ZA202106815B - Crystalline pyrimidinyl-3,8-diazabicyclo[3.2.1]octanylmethanone compound and use thereof - Google Patents

Crystalline pyrimidinyl-3,8-diazabicyclo[3.2.1]octanylmethanone compound and use thereof

Info

Publication number
ZA202106815B
ZA202106815B ZA2021/06815A ZA202106815A ZA202106815B ZA 202106815 B ZA202106815 B ZA 202106815B ZA 2021/06815 A ZA2021/06815 A ZA 2021/06815A ZA 202106815 A ZA202106815 A ZA 202106815A ZA 202106815 B ZA202106815 B ZA 202106815B
Authority
ZA
South Africa
Prior art keywords
diazabicyclo
octanylmethanone
pyrimidinyl
crystalline
compound
Prior art date
Application number
ZA2021/06815A
Other languages
English (en)
Inventor
Xiaojing Yang
Amanda Patrice Surajhie Samuel
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of ZA202106815B publication Critical patent/ZA202106815B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/08—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pain & Pain Management (AREA)
  • Ophthalmology & Optometry (AREA)
ZA2021/06815A 2019-02-15 2021-09-14 Crystalline pyrimidinyl-3,8-diazabicyclo[3.2.1]octanylmethanone compound and use thereof ZA202106815B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201962806180P 2019-02-15 2019-02-15
PCT/IB2020/051128 WO2020165788A1 (en) 2019-02-15 2020-02-12 Crystalline pyrimidinyl-3,8-diazabicyclo[3.2.1]octanylmethanone compound and use thereof

Publications (1)

Publication Number Publication Date
ZA202106815B true ZA202106815B (en) 2026-03-25

Family

ID=69726639

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA2021/06815A ZA202106815B (en) 2019-02-15 2021-09-14 Crystalline pyrimidinyl-3,8-diazabicyclo[3.2.1]octanylmethanone compound and use thereof

Country Status (15)

Country Link
US (2) US12312358B2 (cg-RX-API-DMAC7.html)
EP (1) EP3924355B1 (cg-RX-API-DMAC7.html)
JP (1) JP7561497B2 (cg-RX-API-DMAC7.html)
KR (2) KR102820235B1 (cg-RX-API-DMAC7.html)
CN (1) CN113646310A (cg-RX-API-DMAC7.html)
AR (1) AR118099A1 (cg-RX-API-DMAC7.html)
AU (1) AU2020222083B2 (cg-RX-API-DMAC7.html)
BR (1) BR112021015951A2 (cg-RX-API-DMAC7.html)
CA (1) CA3130034C (cg-RX-API-DMAC7.html)
ES (1) ES3065864T3 (cg-RX-API-DMAC7.html)
MX (1) MX2021009761A (cg-RX-API-DMAC7.html)
SG (1) SG11202108863WA (cg-RX-API-DMAC7.html)
TW (1) TWI820301B (cg-RX-API-DMAC7.html)
WO (1) WO2020165788A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA202106815B (cg-RX-API-DMAC7.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102820235B1 (ko) * 2019-02-15 2025-06-16 화이자 인코포레이티드 결정질 피리미디닐-3,8-다이아자바이사이클로[3.2.1]옥타닐메타논 화합물 및 이의 용도
US12673955B2 (en) 2020-06-09 2026-07-07 Crystal Pharmatech Co., Ltd. Crystal form of p-toluenesulfonate salt of diazabicyclic compound and preparation method therefor
CN114835717A (zh) * 2021-02-01 2022-08-02 杭州领业医药科技有限公司 Brepocitinib甲苯磺酸盐的晶型及其制备方法和用途
CN113461687B (zh) * 2021-08-10 2022-04-19 四川大学华西医院 2,8-氮杂-[4,5]十螺环酮衍生物及其制备方法和用途

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3773919A (en) 1969-10-23 1973-11-20 Du Pont Polylactide-drug mixtures
US4485045A (en) 1981-07-06 1984-11-27 Research Corporation Synthetic phosphatidyl cholines useful in forming liposomes
US4544545A (en) 1983-06-20 1985-10-01 Trustees University Of Massachusetts Liposomes containing modified cholesterol for organ targeting
US5013556A (en) 1989-10-20 1991-05-07 Liposome Technology, Inc. Liposomes with enhanced circulation time
US5023556A (en) 1990-02-02 1991-06-11 Conax Florida Corporation Sensor circuit response to different fluid conductivities and having time delay feature
EA027879B1 (ru) 2013-02-22 2017-09-29 Пфайзер Инк. ПРОИЗВОДНЫЕ ПИРРОЛО[2,3-d]ПИРИМИДИНА В КАЧЕСТВЕ ИНГИБИТОРОВ ЯНУС-РОДСТВЕННЫХ КИНАЗ (JAK)
NO2721710T3 (cg-RX-API-DMAC7.html) 2014-08-21 2018-03-31
KR20260080448A (ko) * 2018-03-30 2026-06-02 인사이트 코포레이션 Jak 억제제를 사용하는 화농성 한선염의 치료
KR102820235B1 (ko) * 2019-02-15 2025-06-16 화이자 인코포레이티드 결정질 피리미디닐-3,8-다이아자바이사이클로[3.2.1]옥타닐메타논 화합물 및 이의 용도

Also Published As

Publication number Publication date
TWI820301B (zh) 2023-11-01
CA3130034C (en) 2023-12-19
US20220144846A1 (en) 2022-05-12
JP2020138960A (ja) 2020-09-03
EP3924355B1 (en) 2025-12-31
KR102820235B1 (ko) 2025-06-16
SG11202108863WA (en) 2021-09-29
AU2020222083A1 (en) 2021-09-02
EP3924355A1 (en) 2021-12-22
EP3924355C0 (en) 2025-12-31
JP7561497B2 (ja) 2024-10-04
KR20240116855A (ko) 2024-07-30
ES3065864T3 (en) 2026-05-08
CA3130034A1 (en) 2020-08-20
AU2020222083B2 (en) 2022-11-17
AR118099A1 (es) 2021-09-15
US20250282789A1 (en) 2025-09-11
US12312358B2 (en) 2025-05-27
TW202045511A (zh) 2020-12-16
MX2021009761A (es) 2021-12-15
CN113646310A (zh) 2021-11-12
BR112021015951A2 (pt) 2021-10-05
KR20210114470A (ko) 2021-09-23
WO2020165788A1 (en) 2020-08-20

Similar Documents

Publication Publication Date Title
ZA202007671B (en) Pharmaceutical combination, composition, and combination formulation containing glucokinase activator and biguanide hypoglycemic drug as well as preparation method and use thereof
PH12022551119A1 (en) New methylquinazolinone derivatives
GEP201606555B (en) Compounds and compositions for modulating egfr activity
WO2020113213A3 (en) Cyclic pantetheine derivatives and uses thereof
PH12020551891A1 (en) New quinoline derivatives
DE602004021472D1 (en) Pyrimiidinverbindungen
AU2003228770A8 (en) Substituted pyrazolopyrimidines
SE0202463D0 (sv) Novel compounds
WO2020127819A3 (en) Pharmaceutical composition comprising apixaban
JOP20220006A1 (ar) مشتقات 3، 6-داي أمينو-بيريدازين-3-يل، تركيبات صيدلية تحتوي عليها واستخدامها في صورة عوامل مساعدة على تلاشي الخلايا
MX2021009761A (es) Compuesto de pirimidinil-3,8-diazabiciclo [3.2.1]octanilmetanona cristalina y uso de este.
MY200061A (en) Irak inhibitor and preparation method therefor and use thereof
SA521422467B1 (ar) مركبات هالو-آلِّيلامين واستخدامها
CR20210181A (es) Inhibidores de o-glicoproteína-2-acetamido-2-desoxi-3-d-glucopiranosidasa
PH12020551342A1 (en) Saturated-ring-fused dihydropyrimidinone or dihydrotriazinone compounds and pharmaceutical use thereof
PH12020552186A1 (en) Cyanotriazole compounds and uses thereof
MY198008A (en) Crystal of benzofuran derivative free base and preparation method
ZA202500857B (en) Compounds and methods for modulating her2
MX2025002355A (es) Compuestos de triazina y usos de los mismos
JOP20220082A1 (ar) مشتقات 2- آزا سبيرو [3.4] أوكتان كناهضات لـ m4
TW200639156A (en) New compounds
MXPA05008960A (es) Oxazolidinonas de indolona antibacteriales, intermedios para su preparacion y composiciones farmaceuticas que las contienen.
HUE072069T2 (hu) 2-((1R,4R)-4-((3-(3-(trifluormetil)fenil)imidazo[1,2- b]piridazin-6-il)amino)ciklohexil)propán-2-ol sósavas sójának kristályos formája
WO2004087652A3 (en) Imidazotriazine compounds
SG11201907945YA (en) Azetidine derivative